U.S. Anterior Uveitis Treatment Market Size & Outlook
U.S. anterior uveitis treatment market, 2018-2030 (US$M)
Related Markets
U.S. anterior uveitis treatment market highlights
- The U.S. anterior uveitis treatment market generated a revenue of USD 166.2 million in 2022 and is expected to reach USD 459.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 13.6% from 2023 to 2030.
- In terms of segment, non-infectious uveitis was the largest revenue generating type in 2022.
- Non-Infectious Uveitis is the most lucrative type segment registering the fastest growth during the forecast period.
Anterior uveitis treatment market data book summary
| Market revenue in 2022 | USD 166.2 million |
| Market revenue in 2030 | USD 459.8 million |
| Growth rate | 13.6% (CAGR from 2022 to 2030) |
| Largest segment | Non-infectious uveitis |
| Fastest growing segment | Non-Infectious Uveitis |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Infectious Uveitis, Non-Infectious Uveitis |
| Key market players worldwide | Novartis AG ADR, Santen Pharmaceutical Co Ltd, AbbVie Inc, Kiora Pharmaceuticals Inc, Clearside Biomedical Inc, Aldeyra Therapeutics Inc, UCB SA, Aciont, Sirion Therapeutics, Lux Biosciences |
Other key industry trends
- In terms of revenue, U.S. accounted for 41.4% of the global anterior uveitis treatment market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. anterior uveitis treatment market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 459.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anterior Uveitis Treatment Market Scope
Anterior Uveitis Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. anterior uveitis treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anterior uveitis treatment market will help companies and investors design strategic landscapes.
Non-infectious uveitis was the largest segment with a revenue share of 83.75% in 2022. Horizon Databook has segmented the U.S. anterior uveitis treatment market based on infectious uveitis, non-infectious uveitis covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. anterior uveitis treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. anterior uveitis treatment market databook
-
Our clientele includes a mix of anterior uveitis treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. anterior uveitis treatment market , including forecasts for subscribers. This country databook contains high-level insights into U.S. anterior uveitis treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. anterior uveitis treatment market size, by type, 2018-2030 (US$M)
U.S. Anterior Uveitis Treatment Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
